Constitutive TLR4 signalling in intestinal epithelium reduces tumor load by increasing apoptosis in APC<sup>Min/+</sup> mice.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 369, doi. 10.1038/onc.2012.581
- By:
- Publication type:
- Article
Works matching IS 09509232 AND DT 2014 AND VI 33 AND IP 3
Results: 14
1
2
Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenance.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 398, doi. 10.1038/onc.2012.585
- By:
- Publication type:
- Article
3
MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 378, doi. 10.1038/onc.2012.575
- By:
- Publication type:
- Article
4
Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 347, doi. 10.1038/onc.2012.586
- By:
- Publication type:
- Article
5
SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 279, doi. 10.1038/onc.2012.595
- By:
- Publication type:
- Article
6
Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 358, doi. 10.1038/onc.2012.582
- By:
- Publication type:
- Article
7
The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 316, doi. 10.1038/onc.2012.594
- By:
- Publication type:
- Article
8
The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 300, doi. 10.1038/onc.2012.601
- By:
- Publication type:
- Article
9
MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 269, doi. 10.1038/onc.2013.55
- By:
- Publication type:
- Article
10
MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 387, doi. 10.1038/onc.2012.574
- By:
- Publication type:
- Article
11
NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 289, doi. 10.1038/onc.2012.580
- By:
- Publication type:
- Article
12
TRIM3, a tumor suppressor linked to regulation of p21<sup>Waf1/Cip1</sup>.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 308, doi. 10.1038/onc.2012.596
- By:
- Publication type:
- Article
13
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 336, doi. 10.1038/onc.2012.587
- By:
- Publication type:
- Article
14
The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor.
- Published in:
- Oncogene, 2014, v. 33, n. 3, p. 326, doi. 10.1038/onc.2012.589
- By:
- Publication type:
- Article